In vitro effects of Ganoderic acid A on NF-κB-mediated inflammatory response in caerulein-stimulated pancreatic acinar cells

This study aimed to investigate Ganoderic acid A’s (GAA) possible effects on inflammation and oxidative stress of caerulein-stimulated pancreatic acinar cells and uncover its effects on acute pancreatitis (AP). A cell model of AP was constructed by treating pancreatic acinar AR42J cells with caerulein. Cell counting kit-8 (CCK-8) assay was used to measure cell viability, while Enzyme-Linked Immunosorbent Assay (ELISA) and 2′,7′-Dichlorofluorescein (DCF) fluorescence assays were used to measure inflammation and oxidative stress. Western blot analysis was used to investigate Nuclear Factor-kappa B (NF-κB) signaling pathway inhibition, focusing on p65 and NF-kappa-B inhibitor alpha (IκBα) phosphorylation states. GAA significantly enhanced cell viability in caerulein-stimulated pancreatic acinar AR42J cells. It also significantly reduced AR42J cells’ inflammatory response. Furthermore, GAA treatment mitigated oxidative stress by decreasing Reactive oxygen species (ROS) production. Lastly, GAA inhibited the NF-κB pathway, as evidenced by decreased p65 and IκBα phosphorylation. By inhibiting NF-B-mediated inflammation, GAA attenuated caerulein-induced AP.

Acute pancreatitis (AP); Ganoderic acid A (GAA); Inflammatory response; Oxidative stress; NF-κB pathway

[1] Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021; 325: 382–390.

[2] Lankisch PG, Apte M, Banks PA. Acute pancreatitis. The Lancet. 2015; 386: 85–96.

[3] Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nature Reviews Gastroenterology & Hepatology. 2019; 16: 479–496.

[4] Siriwardena AK, Jegatheeswaran S, Mason JM; PROCAP investigators. A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial. The Lancet Gastroenterology and Hepatology. 2022; 7: 913–921.

[5] Poulsen VV, Hadi A, Werge MP, Karstensen JG, Novovic S. Circulating biomarkers involved in the development of and progression to chronic pancreatitis—a literature review. Biomolecules. 2024; 14: 239.

[6] Glaubitz J, Asgarbeik S, Lange R, Mazloum H, Elsheikh H, Weiss FU, et al. Immune response mechanisms in acute and chronic pancreatitis: strategies for therapeutic intervention. Frontiers in Immunology. 2023; 14: 1279539.

[7] Jakkampudi A, Jangala R, Reddy BR, Mitnala S, Nageshwar Reddy D, Talukdar R. NF-κB in acute pancreatitis: mechanisms and therapeutic potential. Pancreatology. 2016; 16: 477–488.

[8] Xiang H, Guo F, Tao X, Zhou Q, Xia S, Deng D, et al. Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation. Theranostics. 2021; 11: 4467–4482.

[9] Liu Y, Cui H, Mei C, Cui M, He Q, Wang Q, et al. Sirtuin4 alleviates severe acute pancreatitis by regulating HIF-1α/HO-1 mediated ferroptosis. Cell Death & Disease. 2023; 14: 694.

[10] Zeng P, Chen Y, Zhang L, Xing M. Ganoderma lucidum polysaccharide used for treating physical frailty in China. Progress in Molecular Biology and Translational Science. 2019; 73: 179–219.

[11] Bao H, Li H, Jia Y, Xiao Y, Luo S, Zhang D, et al. Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity. Biochemical Pharmacology. 2021; 188: 114561.

[12] Wan B, Li Y, Sun S, Yang Y, LV Y, Wang L, et al. Ganoderic acid A attenuates lipopolysaccharide-induced lung injury in mice. Bioscience Reports. 2019; 39: BSR20190301.

[13] Pang W, Lu S, Zheng R, Li X, Yang S, Feng Y, et al. Investigation into antiepileptic effect of Ganoderic Acid a and its mechanism in seizure rats induced by pentylenetetrazole. BioMed Research International. 2022; 2022: 5940372.

[14] Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, et al. Acute pancreatitis: diagnosis and treatment. Drugs. 2022; 82: 1251–1276.

[15] Ge P, Luo Y, Okoye CS, Chen H, Liu J, Zhang G, et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomedicine & Pharmacotherapy. 2020; 132: 110770.

[16] Zheng S, Ma J, Zhao X, Yu X, Ma Y. Ganoderic Acid A attenuates IL-1β-induced inflammation in human nucleus pulposus cells through inhibiting the NF-κB pathway. Inflammation. 2022; 45: 851–862.

[17] Wen G, Li T, He H, Zhou X, Zhu J. Ganoderic acid A inhibits bleomycin-induced lung fibrosis in mice. Pharmacology. 2020; 105: 568–575.

[18] Lu X, Xu C, Yang R, Zhang G. Ganoderic acid A alleviates OVA-induced asthma in mice. Inflammation. 2021; 44: 1908–1915.